Gastroenteritis Drugs In Development 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Gastroenteritis (Gastrointestinal) – Drugs In Development, 2021” report has been added to ResearchAndMarkets.com’s offering.

The pipeline guide provides comprehensive information on the therapeutics under development for Gastroenteritis (Gastrointestinal), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Gastroenteritis (Gastrointestinal) pipeline guide also reviews of key players involved in therapeutic development for Gastroenteritis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Unknown stages are 3, 3, 2, 2 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

The pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from the publisher’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Report Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Gastroenteritis (Gastrointestinal).
• The pipeline guide reviews pipeline therapeutics for Gastroenteritis (Gastrointestinal) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Gastroenteritis (Gastrointestinal) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Gastroenteritis (Gastrointestinal) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews latest news related to pipeline therapeutics for Gastroenteritis (Gastrointestinal)

Key Topics Covered:

• Gastroenteritis – Overview
• Gastroenteritis – Therapeutics Assessment
• Gastroenteritis – Companies Involved in Therapeutics Development
• Gastroenteritis – Drug Profiles
• Gastroenteritis – Dormant Projects
• Gastroenteritis – Discontinued Products
• Gastroenteritis – Product Development Milestones
• Gastroenteritis – Discontinued Products, 2021

Companies Mentioned

• Allakos Inc
• Cocrystal Pharma Inc
• Kyowa Kirin Co Ltd
• Lanzhou Institute of Biological Products Co Ltd
• Medicago Inc
• Novo Medi Sciences Pvt Ltd
• RedHill Biopharma Ltd
• Regeneron Pharmaceuticals Inc
• Takeda Pharmaceutical Co Ltd
• UMN Pharma Inc
• Vaxart Inc

For more information about this report visit https://www.researchandmarkets.com/r/e1vsqi

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

[email protected]
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900